An FDA application for TAR-200 to treat BCG-unresponsive high-risk non-muscle-invasive bladder cancer is under real-time ...

The New Brunswick, N.J., pharmaceutical giant said the FDA accepted the application through its Real-Time Oncology Review program, which allows for an earlier submission of topline efficacy and safety ...

Researchers discover novel targets for bladder cancer therapeutics and demonstrate that a new combination of existing drugs, including statins, blocks tumor growth in mice.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Pfizer is expected to rebound in 2025 with growth stabilized and dividend growth to continue. Learn why PFE stock is a Buy.

Pfizer's experimental treatment for a type of bladder cancer significantly improved the time that patients remained free of ...

Pfizer’s “golden egg” has hatched. The subcutaneous PD-1 inhibitor improved outcomes when added to the standard of care in ...

Coleen Nolan isn't one to shy away from taboo topics and now the Loose Women panellist is talking about another issue not ...

Coleen Nolan's candid conversations with her Loose Women co-stars reveal a shared experience that many women face but few ...

A deli owner has seen his aggressive bladder cancer finally shrink by 60 per cent thanks to an experimental drug so new - it doesn't yet have a name. Paul Simmonite, 53, went straight to A&E in ...

Bladder cancer is a cancer that forms in tissues of the bladder. Most bladder cancers are transitional cell carcinomas (cancer that begins in cells that normally make up the inner lining of the ...